Employers discontinuing coverage of GLP-1 medications should be aware that the health benefits their members attain will likely be lost over a little more than a year unless the members find a way to continue on these medications.
Neurological diseases as primary gliopathies: a reassessment of neurocentrism
This article sits within the PlexusDx Education Hub, our library on GLP-1 therapy, weight management protocols, and the genetics that quietly shape metabolic outcomes
The practical application of GLP-1 regimens demands a coalescence of theoretical knowledge and practical adaptability, considering the patient's overall health, concurrent medications, lifestyle, and potential side effects of the drug
The brand stands out due to its high-strength methylcobalamin formulation designed for faster neurological recovery
In response to this ongoing issue, the medical community has worked diligently to develop more effective tools for weight loss